26Sep/13

Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to … – PR Newswire (press release)

Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to …
PR Newswire (press release)
In February 2011, Roche began a Phase 3 registration trial of subcutaneous (SC) MabThera (rituximab), an anticancer biologic, in patients with non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) and submitted a line extension …

and more »

26Sep/13

74% young Hyderabadis old at heart – Times of India


Economic Times

74% young Hyderabadis old at heart
Times of India
HYDERABAD: A staggering 74% of Hyderabadis in their thirties and early forties stood a high risk of developing heart disease as against Mumbai’s 72% and Delhi’s 71%, according to one of India’s biggest studies conducted over a period three years.
Work force in 30-44 age group high on heart disease risk: StudyEconomic Times

all 5 news articles »

26Sep/13

Chronic kidney disease rates increasing in older Americans – NephrologyNews.com


Health and Beauty News (blog)

Chronic kidney disease rates increasing in older Americans
NephrologyNews.com
Chronic kidney disease is becoming more common in Americans aged 80 and older, according to a research letter published online Sept. 24 in the Journal of the American Medical Association. The authors used data from the National Health and Nutrition …
Increasing number among U.S. seniors with chronic kidney diseaseHealth and Beauty News (blog)
Don’t Screen for CKD? Beware!Medscape

all 3 news articles »